256 related articles for article (PubMed ID: 28867783)
1. The Mouse Papillomavirus Infection Model.
Hu J; Cladel NM; Budgeon LR; Balogh KK; Christensen ND
Viruses; 2017 Aug; 9(9):. PubMed ID: 28867783
[TBL] [Abstract][Full Text] [Related]
2. Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer.
Cladel NM; Budgeon LR; Balogh KK; Cooper TK; Brendle SA; Christensen ND; Schell TD; Hu J
Sci Rep; 2017 Dec; 7(1):16932. PubMed ID: 29208932
[TBL] [Abstract][Full Text] [Related]
3. Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).
Uberoi A; Yoshida S; Lambert PF
J Virol Methods; 2018 Mar; 253():11-17. PubMed ID: 29253496
[TBL] [Abstract][Full Text] [Related]
4. Immunity to commensal papillomaviruses protects against skin cancer.
Strickley JD; Messerschmidt JL; Awad ME; Li T; Hasegawa T; Ha DT; Nabeta HW; Bevins PA; Ngo KH; Asgari MM; Nazarian RM; Neel VA; Jenson AB; Joh J; Demehri S
Nature; 2019 Nov; 575(7783):519-522. PubMed ID: 31666702
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.
Jiang RT; Wang JW; Peng S; Huang TC; Wang C; Cannella F; Chang YN; Viscidi RP; Best SRA; Hung CF; Roden RBS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515303
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in preclinical model systems for papillomaviruses.
Christensen ND; Budgeon LR; Cladel NM; Hu J
Virus Res; 2017 Mar; 231():108-118. PubMed ID: 27956145
[TBL] [Abstract][Full Text] [Related]
7. A Novel
Spurgeon ME; Uberoi A; McGregor SM; Wei T; Ward-Shaw E; Lambert PF
mBio; 2019 Mar; 10(2):. PubMed ID: 30837335
[TBL] [Abstract][Full Text] [Related]
8. T cell-mediated antitumor immune response eliminates skin tumors induced by mouse papillomavirus, MmuPV1.
Joh J; Chilton PM; Wilcher SA; Zahin M; Park J; Proctor ML; Ghim SJ; Jenson AB
Exp Mol Pathol; 2017 Oct; 103(2):181-190. PubMed ID: 28939161
[TBL] [Abstract][Full Text] [Related]
9. Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.
Scagnolari C; Cannella F; Pierangeli A; Mellinger Pilgrim R; Antonelli G; Rowley D; Wong M; Best S; Xing D; Roden RBS; Viscidi R
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295905
[TBL] [Abstract][Full Text] [Related]
10. Secondary infections, expanded tissue tropism, and evidence for malignant potential in immunocompromised mice infected with Mus musculus papillomavirus 1 DNA and virus.
Cladel NM; Budgeon LR; Cooper TK; Balogh KK; Hu J; Christensen ND
J Virol; 2013 Aug; 87(16):9391-5. PubMed ID: 23785210
[TBL] [Abstract][Full Text] [Related]
11. Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic trichoblastomas.
Sundberg JP; Stearns TM; Joh J; Proctor M; Ingle A; Silva KA; Dadras SS; Jenson AB; Ghim SJ
PLoS One; 2014; 9(12):e113582. PubMed ID: 25474466
[TBL] [Abstract][Full Text] [Related]
12. Role of Ultraviolet Radiation in Papillomavirus-Induced Disease.
Uberoi A; Yoshida S; Frazer IH; Pitot HC; Lambert PF
PLoS Pathog; 2016 May; 12(5):e1005664. PubMed ID: 27244228
[TBL] [Abstract][Full Text] [Related]
13. Host defence and persistent human papillomavirus infection.
Stanley M
Curr Opin Virol; 2021 Dec; 51():106-110. PubMed ID: 34628358
[TBL] [Abstract][Full Text] [Related]
14. The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues.
Xue XY; Majerciak V; Uberoi A; Kim BH; Gotte D; Chen X; Cam M; Lambert PF; Zheng ZM
PLoS Pathog; 2017 Nov; 13(11):e1006715. PubMed ID: 29176795
[TBL] [Abstract][Full Text] [Related]
15. Mouse model of cervicovaginal papillomavirus infection.
Çuburu N; Cerio RJ; Thompson CD; Day PM
Methods Mol Biol; 2015; 1249():365-79. PubMed ID: 25348320
[TBL] [Abstract][Full Text] [Related]
16. MmuPV1 infection and tumor development of T cell-deficient mice is prevented by passively transferred hyperimmune sera from normal congenic mice immunized with MmuPV1 virus-like particles (VLPs).
Joh J; Ghim SJ; Chilton PM; Sundberg JP; Park J; Wilcher SA; Proctor ML; Bennett Jenson A
Exp Mol Pathol; 2016 Feb; 100(1):212-9. PubMed ID: 26778691
[TBL] [Abstract][Full Text] [Related]
17. Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species.
Handisurya A; Day PM; Thompson CD; Buck CB; Kwak K; Roden RB; Lowy DR; Schiller JT
Virology; 2012 Nov; 433(2):385-94. PubMed ID: 22985477
[TBL] [Abstract][Full Text] [Related]
18. The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.
King RE; Rademacher J; Ward-Shaw ET; Hu R; Bilger A; Blaine-Sauer S; Spurgeon ME; Thibeault SL; Lambert PF
Laryngoscope; 2024 May; 134(5):2322-2330. PubMed ID: 38084790
[TBL] [Abstract][Full Text] [Related]
19. The human papillomavirus 16 E5 gene potentiates MmuPV1-Dependent pathogenesis.
Torres AD; Spurgeon ME; Bilger A; Blaine-Sauer S; Uberoi A; Buehler D; McGregor SM; Ward-Shaw E; Lambert PF
Virology; 2020 Feb; 541():1-12. PubMed ID: 31826841
[TBL] [Abstract][Full Text] [Related]
20. Mus musculus Papillomavirus 1: a New Frontier in Animal Models of Papillomavirus Pathogenesis.
Spurgeon ME; Lambert PF
J Virol; 2020 Apr; 94(9):. PubMed ID: 32051276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
